Plasmodium spp. is the etiological agent of malaria, a life-threatening parasitic disease
transmitted by infected mosquitoes. Malaria remains a major global health challenge …

The versatile potential of bacteriophage MS2-derived virus-like particles (VLPs) in medical
biotechnology has been extensively studied during the last 30 years. Since the first reports …

Background BK-SE36/CpG is a recombinant blood-stage malaria vaccine candidate based
on the N-terminal Plasmodium falciparum serine repeat antigen5 (SE36), adsorbed to …

The emergence of resistance to first-line antimalarial drugs calls for the development of new
therapies for drug-resistant malaria. The efficacy of quinoline-based antimalarial drugs has …

Plasmodium falciparum is the main causative agent of malaria, a deadly disease that mainly
affects children under five years old. Artemisinin-based combination therapies have been …

Malaria is the deadliest parasitic disease in the world. Traditional control measures have
become less effective; hence, there is a need to explore alternative strategies, such as …

Malaria vaccine introduction in endemic countries is a game-changing milestone in the fight
against the disease. This article examines the inequity in the global pharmaceutical …

Malaria, transmitted through the bite of a Plasmodium-infected Anopheles mosquito,
remains a significant global health concern. This review examines the complex life cycle of …

This paper introduces a novel approach to modeling malaria incidence in Nigeria by
integrating clustering strategies with regression modeling and leveraging meteorological …

Microalgal emergence is a promising platform with two‐decade historical background for
producing vaccines and biopharmaceuticals. During that period, microalgal‐based vaccines …